An Innovative Biopharmaceutical Company Advancing a Cutting-Edge Pipeline of Therapeutic Innovations
At Essen Biotech, we are committed to pioneering cutting-edge therapies that harness the power of the immune system to combat cancer, genetic disorders, and autoimmune diseases.
Our diverse pipeline encompasses a range of advanced therapies, including CAR-T, TILs, and CRISPR-Cas9 gene editing, aimed at transforming patient outcomes and providing hope to those battling life-threatening conditions.
From discovery through to clinical trials, our rigorous development process reflects our dedication to quality, safety, and efficacy in every stage. Explore our current pipeline to see how we are pushing the boundaries of modern medicine to bring tomorrow’s treatments to life today.
NCT06213636
Phase 2
NCT06420076
Phase 2
NCT06532719
Phase 2
NCT06420063
Phase 2
NCT06538012
Phase 2
NCT06532812
Phase 2
NCT06532799
Phase 2
NCT06530303
Phase 2
NCT06640582
Phase 2
NCT06428188
Phase 2
NCT06532799
Phase 2
NCT06399107
Phase 2
NCT06399107
Phase 2
NCT06399107
Phase 2
ESSEN BIOTECH Clinical Trials in Discovery Phase
Cytotoxic T Lymphocytes (CTLs) Therapy
Discovery
MSC Stem Cell Therapy
Discovery
NK Cell Immunotherapy
Discovery
Peripheral Blood Lymphocyte (PBL) Therapy
Discovery
Impact and Excellence
These numbers illustrate more than our capabilities—they embody our mission to bring transformative treatments to patients, foster innovation, and lead in the development of cutting-edge biotechnological solutions.
At Essen Biotech, we are driven by the belief that every milestone achieved translates to hope, progress, and improved outcomes for patients around the world.
Essen Biotech’s innovative therapies are designed to address the unmet needs of patients across the globe.
With each milestone we achieve, we move closer to transforming lives and redefining what is possible in healthcare.
Our pipeline reflects years of research, collaboration, and a relentless drive for excellence in pursuit of effective treatments. Join us on this journey as we continue to advance our therapies through clinical stages, aiming for FDA and global approvals that will bring these life-changing treatments to patients who need them most.
Contact
At Essen Biotech, we are committed to fostering connections with patients, healthcare professionals, researchers, and partners around the globe.
Whether you are interested in learning more about our therapies, participating in clinical trials, or exploring collaboration opportunities, our team is here to assist you.
Contact Number: +44 7418621773
United Kingdom Regional Office
Contact Number: +973 17777166
Kingdom Of Bahrain Regional Office
Contact Number: +1 2077706670